Stocktoria

AbbVie Inc. ABBV

NYSE · stock · Pharmaceutical Preparations · website · IPO 2013-01-02 · LEI

AbbVie Inc. statistics & valuation

Market cap$447.6B
P / E105.9×
P / S7.3×
P / FCF25.1×
Dividend yield2.60%
Net margin6.9%
FCF margin29.1%
Net debt$59.3B
Net debt / EBITDA3.7×
Enterprise value USD$506.9B
EV / EBITDA32×
Earnings yield EBIT/EV3%
Return on capital16.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
23.20% 18.80% 17.40% 23.70% 10.10% 20.50% 20.40% 9.00% 7.60% 6.90% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
36.40% 33.80% 19.50% 39.00% 24.80% 31.90% 31.20% 23.50% 16.20% 24.60% 2016201720182019202020212022202320242025
Return on equity (%)
128.40% 104.20% 35.20% 74.80% 68.50% 46.80% 127.20% 2016201720182019202020212022202320242025
Shares outstanding
1.63B 1.60B 1.55B 1.48B 1.67B 1.78B 1.78B 1.77B 1.77B 1.77B 2016201720182019202020212022202320242025
Net debt ($)
$27.31B $76.50B $66.22B $53.93B $46.43B $61.32B $59.27B 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
9.00% 7.50% 9.60% 8.80% 3.10% 7.90% 8.50% 3.60% 3.20% 3.20% 2016201720182019202020212022202320242025
Free cash flow margin (%)
25.60% 33.40% 39.00% 38.40% 36.70% 39.10% 41.80% 40.60% 31.70% 29.10% 2016201720182019202020212022202320242025
Debt / equity (×)
6.49× 4.92× 3.65× 5.70× 19.87× 2016201720182019202020212022202320242025
EPS ($)
$3.63 $3.30 $3.66 $5.28 $2.72 $6.45 $6.63 $2.72 $2.39 $2.36 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

AbbVie Inc. trades at about 105.4× earnings — above its 10-year norm (10-year range 15.3×–94.5×, median 34×).

15.3× 105.4×

Shaded band = 10-year range (15.3×–94.5×); dot = today's 105.4×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin24.6%16.2%23.5%31.2%31.9%24.8%39.0%19.5%33.8%36.4%
Net margin6.9%7.6%9.0%20.4%20.5%10.1%23.7%17.4%18.8%23.2%
FCF margin29.1%31.7%40.6%41.8%39.1%36.7%38.4%39.0%33.4%25.6%
Return on assets3.2%3.2%3.6%8.5%7.9%3.1%8.8%9.6%7.5%9.0%
Return on equity-129.2%127.2%46.8%68.5%74.8%35.2%-96.5%-67.3%104.2%128.4%
Debt / equity-19.73×19.87×5.70×3.65×4.92×6.49×-8.23×———
Current ratio0.670.660.870.960.790.843.180.981.281.65

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.